Attorney General Letitia James has secured a major settlement with pharmaceutical company Mylan Inc., marking the latest in a ...

Delaware’s top attorney helped secure up to $335 million from another pharmaceutical company that helped fuel the opioid ...

A pharmaceutical company has agreed in principle to pay hundreds of millions of dollars which officials say will help combat ...

Officials say Mylan falsely advertised its opioid products as less addictive for years and marketed directly to doctors, resulting in overprescribing and illegal drug trade of its ...

Illinois, along with 13 other states, has reached a $335 million settlement with Mylan Inc. over allegations the company deceptively promoted its opioid products as being less prone to abuse.

Delaware Attorney General Kathy Jennings announces a multi-state settlement with Mylan Inc. This settlement will deliver up ...

Mylan, the company that came under fire this summer for systematically raising the price of the EpiPen, is caught up in another drug price scheme. The pharmaceutical player is one of six companies ...

Mylan has launched its generic version of GlaxoSmithKline’s respiratory blockbuster, Advair, at a 70% discount compared with the original drug. Cheaper competition to off-patent Advair has been ...

The first copycat Lantus – Eli Lilly/Boehringer Ingelheim's Basaglar – was approved in the US in 2017, but that was approved as under a new drug application, not as a biosimilar, and so also ...

This leaflet answers some common questions about RABEPRAZOLE MYLAN. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.